Vaccine Production Challenges
As the pandemic surged, scientists faced immense pressure to quickly pivot to coronavirus vaccine production, leading to a collective sense of urgency. India’s Serum Institute is at the forefront, producing vaccines that require standard refrigeration, making them accessible for low and middle-income countries. The debate over patent suspensions highlights the tension between innovation and the urgent need for widespread vaccination, with experts advocating for a balanced approach that supports both access and ongoing development.In this clip
From this podcast
Short Wave
A Look Inside The World's Biggest Vaccine Maker
Related Questions